J&J’s ketamine nasal spray for depression continues to impress
April 16, 2018Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical
New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
Keytruda continues success with new Phase 3 data in adjuvant melanoma
April 16, 2018Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer
MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Visit Us! DIA’s Refreshed Homepage Design
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …
PrimeVigilance celebrates its 10th anniversary
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance
PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …
Top Ten most popular articles on Pharmafile.com this week
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten
It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …
Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso
April 13, 2018Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma
South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
Evolutionary path of kidney cancer tracked, “born to be bad” type discovered
April 13, 2018Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical
A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
Eisai forms partnership to find new tuberculosis treatment
April 13, 2018Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago
Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
Roche’s immunotherapy lucky streak ends with deaths in trial
April 13, 2018Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
Wickham Labs Announces Upcoming Webinar on Regulatory Changes in Medical Device Development
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories
Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …
Ipsen bolsters executive leadership with two new recruits
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
New hepatitis C combo boasts 97% cure rate for just $300
April 12, 2018Research and Development AbbVie, DNDi, Drugs for Neglected Diseases initiative, Gilead, HCV, Pharco Pharmaceuticals, hepatitis C, pharma, sovaldi
A partnership of the not-for-profit organisation Drugs for Neglected Diseases initiative (DNDi) and Egyptian drug firm Pharco Pharmaceuticals is working …
EMA announces second-ever public hearing on high-use antibiotics
April 12, 2018Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical
The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …
Working Life: Kris Sterkens, Company Group Chairman, Janssen EMEA
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, Kris Sterkens, pharma
Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …
Alzheimer’s protein treatment that works in human cells
April 12, 2018Research and Development Alzheimer's disease, Gladstone Institutes, biotech, drugs, pharma, pharmaceutical
One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …
Sanofi to invest €350m in new Canadian vaccine plant
April 12, 2018Manufacturing and Production Canada, Sanofi, pharma, vaccines
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, …
Bayer contraceptive implant public backlash brings results
April 12, 2018Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
Verona Pharma loses Chief Medical Officer
April 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma
Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
AbbVie’s rheumatoid arthritis drug bests even its own blockbuster Humira at Phase 3
April 11, 2018Research and Development AbbVie, Humira, pharma, rheumatoid arthritis, upadacitinib
AbbVie posted a strong showing this week from its JAK1 inhibitor upadacitinib, indicating that the drug outperformed even its own …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
